However, sema3C also functions as a potent inhibitor of angiogenesis and lymphangiogenesis, which is likely mediated by the activation of plexin-D1-dependent signal transduction in endothelial cells and lymphatic endothelial cells [48,85], resulting in the inhibition of tumor progression. The gene discussed is SEMA3C; the disease is neoplasm.